Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

Saved in:
Bibliographic Details
Title: Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.
Authors: Stein Gold L; Henry Ford Health System, West Bloomfield, MI, USA., Armstrong AW; Department of Dermatology, University of California Los Angeles, Los Angeles, CA, USA., Soung J; Southern California Clinical Research, Santa Ana and Harbor University of California Los Angeles, CA, USA., Vender RB; McMaster University and Dermatrials Research Inc., Hamilton, ON, Canada., González Cantero Á; Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.; Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain., Hoffmann M; Dermatology Practice Dr. Matthias Hoffmann, Witten, Germany., Guenthner ST; The Indiana Clinical Trials Center, PC, Plainfield, IN, USA.; The Dermatology Center of Indiana, PC, Plainfield, IN, USA., Hong HC; University of British Columbia, Department of Dermatology and Skin Science, Vancouver, BC, Canada.; Dr. Chih-Ho Hong Medical Inc., a member of Probity Medical Research, Surrey, BC, Canada., Murrell DF; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia., Song EJ; Frontier Dermatology, Mill Creek, WA, USA., Kircik L; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana University School of Medicine, Indianapolis, IN, USA., Augustin M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sauder M; Probity Medical Research, Waterloo, ON, Canada.; University of Toronto, Toronto, ON, Canada., Gerdes S; Center for Inflammatory Skin Diseases, Department of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany., Reyes-Servin O; Johnson & Johnson, Spring House/Horsham, PA, USA., Edem BE; Johnson & Johnson, Leiden, The Netherlands., Campbell J; Johnson & Johnson, Cambridge, MA, USA., Cresswell K; Johnson & Johnson, Spring House/Horsham, PA, USA., Kephart L; Johnson & Johnson, Spring House/Horsham, PA, USA., Li S; Johnson & Johnson, Spring House/Horsham, PA, USA., Yang YW; Johnson & Johnson, Spring House/Horsham, PA, USA., Bissonnette R; Innovaderm Research, Montreal, QC, Canada.
Source: The British journal of dermatology [Br J Dermatol] 2026 Jul 03. Date of Electronic Publication: 2026 Jul 03.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2133
DOI:10.1093/bjd/ljag264